The Use of Quetiapine (Seroquel) in the Treatment of Social Phobia: Public Speaking Environment
Status:
Completed
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
This is a pilot study that will focus on the collection of preliminary data to determine the
efficacy of quetiapine for individuals with social phobia. We hypothesize that individuals
will react with less self-reported anxiety and physiological reactivity in the drug condition
than in the placebo condition. If true, this would constitute a strong signal for a
significant treatment effect for quetiapine in social phobia. A positive treatment effect in
this study would provide rationale for further investigation of the efficacy of quetiapine
for cue reactivity for individuals with social phobia. Further study would include increased
sample size in order to obtain statistical power and replication of findings. We will utilize
the IR formulation of quetiapine.
Phase:
Phase 4
Details
Lead Sponsor:
University of Minnesota University of Minnesota - Clinical and Translational Science Institute